Contact Us
Subscribe
E-Edition

69°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
Sports
Obits
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Subscribe
Archives
Best of 2026

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

79.92 -22.24 (-21.77%)

Streaming Delayed Price Updated: 10:14 AM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

72 73 Next >

Why Is Novavax (NVAX) Stock Falling Today? ↗

September 22, 2022

Novavax still has cash, but it needs to get approval for another vaccine if NVAX stock is to be worth buying again.

Via InvestorPlace

Nikola, Super Micro Computer And Other Big Losers From Monday ↗

September 20, 2022

U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Check Out What Whales Are Doing With BNTX ↗

September 19, 2022

Someone with a lot of money to spend has taken a bullish stance on BioNTech (NASDAQ:BNTX). And retail traders should know. We noticed this today when the big position showed up on publicly available...

Via Benzinga

Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today? ↗

September 19, 2022

Vaccine stocks are taking it on the chin following President Joe Biden's comments that the "pandemic is over." What now?

Via InvestorPlace

Why BioNTech, Moderna And Novavax Shares Are Diving ↗

September 19, 2022

BioNTech SE - ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) and Novavax, Inc. (NASDAQ: NVAX) are all trading lower during Mo

Via Benzinga

Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine ↗

September 14, 2022

Via Benzinga

The Silver Lining For Pfizer, Moderna In This Month's IBD/TIPP Poll ↗

September 15, 2022

The companies recently launched their updated Covid booster shots.

Via Investor's Business Daily

Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary ↗

September 12, 2022

Via Benzinga

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union

September 12, 2022

From Pfizer Inc.

Via Business Wire

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary ↗

September 09, 2022

Via Benzinga

Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report ↗

September 06, 2022

Via Benzinga

White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗

September 02, 2022

Via Benzinga

Moderna, BioNTech Jump After CDC Green-Lights Updated Covid Boosters ↗

September 02, 2022

These new shots target the BA.4 and BA.5 subvariants of omicron.

Via Investor's Business Daily

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

September 01, 2022

Via Benzinga

Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines ↗

September 01, 2022

Health Canada has approved Moderna Inc's (NASDAQ:

Via Benzinga

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union

September 01, 2022

From Pfizer Inc.

Via Business Wire

Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash... ↗

September 01, 2022

Wall Street Journal

Via Benzinga

Why Novavax Shares Are Getting Hammered After Moderna, Pfizer And BioNTech News ↗

August 31, 2022

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc (NASDAQ: MRNA) receiving FDA authorization for emergency use...

Via Benzinga

Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older

August 31, 2022

From Pfizer Inc.

Via Business Wire

Pfizer, Moderna Nab FDA Authorization For Updated Covid Boosters ↗

August 31, 2022

Boosters are recommended two months out from the last shot.

Via Investor's Business Daily

Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30 ↗

August 30, 2022

Reuters Taiwan’s China Airlines Orders 16 Boeing 787s

Via Benzinga

US Stock Futures Higher Ahead Of Economic Data, Fed Speakers ↗

August 30, 2022

Pre-open movers U.S. stock futures traded higher in early pre-market trade as investors digested comments from Federal Reserve Chairman Jerome Powell. Markets closed lower again on Monday, with the...

Via Benzinga

Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report ↗

August 30, 2022

Booster shots for Omicron variants of the novel coronavirus could officially be made available in the U.S. just after Labor Day, Politico reported on Monday.

Via Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

August 26, 2022

Via Benzinga

Pfizer/BioNTech Complete European Submission For Omicron Subvariant Adapted Vaccine ↗

August 26, 2022

Via Benzinga

Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine

August 26, 2022

From Pfizer Inc.

Via Business Wire

Moderna Claims Pfizer, BioNTech Stole Its Patented Tech In Covid Shot ↗

August 26, 2022

The lawsuit alleges Comirnaty violates Moderna's patents from 2010-16.

Via Investor's Business Daily

Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know ↗

August 26, 2022

Moderna Inc (NASDAQ: MRNA) has

Via Benzinga

Pfizer And Moderna Are In A Race With Omicron; Will The Vaccine Stocks Be Too Late? ↗

August 26, 2022

The companies hope to launch updated boosters this fall. This is what experts think of their prospects.

Via Investor's Business Daily

AstraZeneca's CEO Says There Are No COVID Regrets, Looks For Oncology Acquisitions ↗

August 24, 2022

In a Reuters report, AstraZeneca Plc's (NASDAQ:

Via Benzinga

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

starkvilledailynews.com
304 E. Lampkin Street,
Starkville, MS 39759
Phone: 662-323-1642
Email: editor@starkvilledailynews.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

BioNTech SE - American Depositary Shares (NQ:BNTX)

All News about BioNTech SE - American Depositary Shares

Sections

Services

Follow Us